Kestra Medical Technologies, Ltd.
KMTSNASDAQHealthcare● Active
$20.07
+$0.67(+3.45%)
Market Cap$1.2B
P/E Ratio—
52W High$30
52W Low$13.25
Kestra Medical Technologies, Ltd. (KMTS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
KMTS · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Mar 17, 2026EPS Actual
-$0.61
Est. -$0.60 · -1.7%
Revenue
$0.02B
Est. $0.02B · +7.3%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Mar 17, 2026
After Market Close
▼ Miss EPS▲ Beat Revenue
KMTS reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Jul 21, 2026 | -$0.59 | — | — | — | $0.03B | — |
| ▼ Q1 FY2026 | Mar 17, 2026 | -$0.60 | -$0.61 | -1.7% | $0.02B | $0.02B | +7.3% |
| ▼ Q4 FY2025 | Dec 11, 2025 | -$0.59 | -$0.62 | -4.4% | $0.02B | $0.02B | -1.3% |
| ▲ Q3 FY2025 | Sep 11, 2025 | -$0.66 | -$0.46 | +30.3% | $0.02B | $0.02B | -6.5% |
| — Q3 FY2025 | Jul 17, 2025 | — | -$1.05 | — | $0.02B | — | — |
| ▼ Q2 FY2025 | Apr 14, 2025 | -$0.60 | -$1.25 | -107.2% | $0.02B | $0.02B | +0.1% |
| — Q2 FY2024 | Apr 30, 2024 | — | -$0.45 | — | $0.01B | — | — |
| — Q1 FY2024 | Jan 31, 2024 | — | -$0.44 | — | $0.01B | — | — |
Q3 FY2026
Jul 21, 2026
EPS Actual
—
EPS Est.
-$0.59
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 17, 2026Miss
EPS Actual
-$0.61
EPS Est.
-$0.60
EPS Surpr.
-1.7%
Revenue
$0.02B
Q4 FY2025
Dec 11, 2025Miss
EPS Actual
-$0.62
EPS Est.
-$0.59
EPS Surpr.
-4.4%
Revenue
$0.02B
Q3 FY2025
Sep 11, 2025Beat
EPS Actual
-$0.46
EPS Est.
-$0.66
EPS Surpr.
+30.3%
Revenue
$0.02B
Q3 FY2025
Jul 17, 2025
EPS Actual
-$1.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.02B
Q2 FY2025
Apr 14, 2025Miss
EPS Actual
-$1.25
EPS Est.
-$0.60
EPS Surpr.
-107.2%
Revenue
$0.02B
Q2 FY2024
Apr 30, 2024
EPS Actual
-$0.45
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2024
Jan 31, 2024
EPS Actual
-$0.44
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $-0.40 | $-0.40 | $-0.39 | 1 |
| Q1 FY2028 | $-0.43 | $-0.42 | $-0.42 | 1 |
| Q4 FY2027 | $-0.44 | $-0.44 | $-0.44 | 1 |
| Q3 FY2027 | $-0.50 | $-0.49 | $-0.49 | 1 |
| Q2 FY2027 | $-0.52 | $-0.52 | $-0.52 | 1 |
| Q1 FY2027 | $-0.56 | $-0.56 | $-0.56 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q2 FY2028 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Mar 17, 2026 | -1.7% | $19.26 | $21.14 | +9.76% |
| ▼ Q4 FY2025 | Dec 11, 2025 | -4.4% | $24.52 | $24.91 | +1.59% |
| ▲ Q3 FY2025 | Sep 11, 2025 | +30.3% | $18.19 | $18.40 | +1.15% |
| — Q3 FY2025 | Jul 17, 2025 | — | $15.35 | $16.46 | +7.23% |
| ▼ Q2 FY2025 | Apr 14, 2025 | -107.2% | $24.28 | $23.83 | -1.85% |
| — Q2 FY2024 | Apr 30, 2024 | — | No price data | $21.84 | — |
| — Q1 FY2024 | Jan 31, 2024 | — | No price data | $21.84 | — |
| — Q3 FY2021 | Jul 31, 2021 | — | No price data | $21.84 | — |
Q1 FY2026+9.76%
Report Date
Mar 17, 2026
EPS Beat/Miss
-1.7%
Price Before
$19.26
Price After
$21.14
Q4 FY2025+1.59%
Report Date
Dec 11, 2025
EPS Beat/Miss
-4.4%
Price Before
$24.52
Price After
$24.91
Q3 FY2025+1.15%
Report Date
Sep 11, 2025
EPS Beat/Miss
+30.3%
Price Before
$18.19
Price After
$18.40
Q3 FY2025+7.23%
Report Date
Jul 17, 2025
EPS Beat/Miss
—
Price Before
$15.35
Price After
$16.46
Q2 FY2025-1.85%
Report Date
Apr 14, 2025
EPS Beat/Miss
-107.2%
Price Before
$24.28
Price After
$23.83
Q2 FY2024—
Report Date
Apr 30, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$21.84
Q1 FY2024—
Report Date
Jan 31, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$21.84
Q3 FY2021—
Report Date
Jul 31, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$21.84
Avg Beat Reaction+1.15%
Avg Miss Reaction+3.17%
Beat Rate1 / 8 quarters
Largest Move+9.76% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: KMTS ends December
Kestra Medical Technologies, Ltd. (KMTS) most recently reported earnings on March 17, 2026 for Q1 FY2026, posting EPS of $-0.61 — missing the analyst consensus of $-0.60 by -1.7%. The next KMTS earnings date is expected around September 1, 2026.
Each quarter, investors track KMTS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. KMTS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
KMTS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
KMTS earnings · 5 questionsKestra Medical Technologies, Ltd.'s next earnings report is expected around September 1, 2026. KMTS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; KMTS historically reports after market close (AMC).
KMTS earnings datewhen is KMTS earningsKMTS next earnings datewhen does KMTS report earningsKMTS earnings calendar
▸ Source: FMP · Kestra Medical Technologies, Ltd. SEC filings · US GAAP · Kestra Medical Technologies, Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026